COMPANYSYMBOLTYPEPRICESharesTrade DateUNDERWRITER (S)
Medovex Corp.MDVXIPOPriced at $5.751.39 million0/0/0Laidlaw & Company
PhaseRx, Inc.PZRXIPO$5.00-$7.003.7 million5/18/2016Laidlaw & Co., Roth Capital Partners
Viking Therapeutics, Inc.VKTXIPO$10.00-$12.003 million4/29/2015Laidlaw & Company (UK) Ltd.

© 2005 - 2024 IPO Boutique. All Rights Reserved